CD38 modifications in chronic lymphocytic leukemia: are they relevant?

被引：18
作者：
Ghia, P
Guida, G
Scielzo, C
Geuna, M
Caligaris-Cappio, F
机构：
[1] Univ Turin, Inst Canc Res & Treatment, Dept Oncol Sci, I-10060 Candiolo, TO, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
LEUKEMIA | 2004年 / 18卷 / 10期
关键词：
D O I：
10.1038/sj.leu.2403504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1733 / 1735
页数：3
相关论文
共 10 条
  • [1] Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course
    Chang, CC
    Cleveland, RP
    [J]. BLOOD, 2002, 100 (03) : 1106 - 1106
  • [2] CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
    Chevallier, P
    Penther, D
    Avet-Loiseau, H
    Robillard, N
    Ifrah, N
    Mahé, B
    Hamidou, M
    Maisonneuve, H
    Moreau, P
    Jardel, H
    Harousseau, JL
    Bataille, R
    Garand, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) : 142 - 150
  • [3] CD38 expression does not change in B-cell chronic lymphocytic leukemia
    D'Arena, G
    Nunziata, G
    Coppola, G
    Vigilotti, ML
    Tartarone, A
    Carpinelli, N
    Matera, R
    Bisogno, RC
    Pistolese, G
    Di Renzo, N
    [J]. BLOOD, 2002, 100 (08) : 3052 - 3053
  • [4] Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
    Damle, RN
    Wasil, T
    Fais, F
    Ghiotto, F
    Valetto, A
    Allen, SL
    Buchbinder, A
    Budman, D
    Dittmar, K
    Kolitz, J
    Lichtman, SM
    Schulman, P
    Vinciguerra, VP
    Rai, KR
    Ferrarini, M
    Chiorazzi, N
    [J]. BLOOD, 1999, 94 (06) : 1840 - 1847
  • [5] CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
    Dürig, J
    Naschar, M
    Schmücker, U
    Renzing-Köhler, K
    Hölter, T
    Hüttmann, A
    Dührsen, U
    [J]. LEUKEMIA, 2002, 16 (01) : 30 - 35
  • [6] The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression
    Ghia, P
    Guida, G
    Stella, S
    Gottardi, D
    Geuna, M
    Strola, G
    Scielzo, C
    Caligaris-Cappio, F
    [J]. BLOOD, 2003, 101 (04) : 1262 - 1269
  • [7] CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease
    Hamblin, TJ
    Orchard, JA
    Ibbotson, RE
    Davis, Z
    Thomas, PW
    Stevenson, FK
    Oscier, DG
    [J]. BLOOD, 2002, 99 (03) : 1023 - 1029
  • [8] CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
    Ibrahim, S
    Keating, M
    Do, KA
    O'Brien, S
    Huh, YO
    Jilani, I
    Lerner, S
    Kantarjian, HM
    Albitar, M
    [J]. BLOOD, 2001, 98 (01) : 181 - 186
  • [9] VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
    Kröber, A
    Seiler, T
    Benner, A
    Bullinger, L
    Brückle, E
    Lichter, P
    Döhner, H
    Stilgenbauer, S
    [J]. BLOOD, 2002, 100 (04) : 1410 - 1416
  • [10] CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL
    Pittner, BT
    Jelinek, DF
    Kay, NE
    [J]. LEUKEMIA, 2004, 18 (01) : 180 - 182
1